| Authors: |
Turkalj S; Medical Research Council Molecular Haematology Unit, Radcliffe Department of Medicine, Weatherall Institute of Medicine, University of Oxford, Oxford, United Kingdom., Radtke FA; Medical Research Council Molecular Haematology Unit, Radcliffe Department of Medicine, Weatherall Institute of Medicine, University of Oxford, Oxford, United Kingdom., Stoilova B; Medical Research Council Molecular Haematology Unit, Radcliffe Department of Medicine, Weatherall Institute of Medicine, University of Oxford, Oxford, United Kingdom., Mecklenbrauck R; Medical Research Council Molecular Haematology Unit, Radcliffe Department of Medicine, Weatherall Institute of Medicine, University of Oxford, Oxford, United Kingdom., Groom AJ; Medical Research Council Molecular Haematology Unit, Radcliffe Department of Medicine, Weatherall Institute of Medicine, University of Oxford, Oxford, United Kingdom., Jakobsen NA; Medical Research Council Molecular Haematology Unit, Radcliffe Department of Medicine, Weatherall Institute of Medicine, University of Oxford, Oxford, United Kingdom., Lachowiez CA; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Metzner M; Medical Research Council Molecular Haematology Unit, Radcliffe Department of Medicine, Weatherall Institute of Medicine, University of Oxford, Oxford, United Kingdom., Usukhbayar B; Medical Research Council Molecular Haematology Unit, Radcliffe Department of Medicine, Weatherall Institute of Medicine, University of Oxford, Oxford, United Kingdom., Salazar MA; Medical Research Council Molecular Haematology Unit, Radcliffe Department of Medicine, Weatherall Institute of Medicine, University of Oxford, Oxford, United Kingdom., Zeng Z; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Loghavi S; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX., Marvin-Peek J; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Körber V; Medical Research Council Molecular Haematology Unit, Radcliffe Department of Medicine, Weatherall Institute of Medicine, University of Oxford, Oxford, United Kingdom., Ravandi F; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Issa G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Kadia T; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Symeonidou V; Medical Research Council Molecular Haematology Unit, Radcliffe Department of Medicine, Weatherall Institute of Medicine, University of Oxford, Oxford, United Kingdom., de Groot AP; Medical Research Council Molecular Haematology Unit, Radcliffe Department of Medicine, Weatherall Institute of Medicine, University of Oxford, Oxford, United Kingdom., Kantarjian H; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Takahashi K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Konopleva M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., DiNardo CD; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Vyas P; Medical Research Council Molecular Haematology Unit, Radcliffe Department of Medicine, Weatherall Institute of Medicine, University of Oxford, Oxford, United Kingdom.; Department of Haematology, Oxford University Hospitals NHS Trust, Oxford, United Kingdom. |
